Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Overcount is a biotechnology company that develops automated cell counting solutions specifically designed for cell therapy manufacturing. The company's platform leverages computer vision and specialized hardware to replace manual hemocytometry with a faster, more accurate, and cost-effective alternative. By providing real-time data on cell concentration and viability, Overcount enables more efficient production of advanced therapies like CAR-T. Their technology is built to be scalable and easily integrated into existing bioprocessing workflows, addressing a critical bottleneck in the manufacturing of personalized medicines. The system is designed to reduce human error and labor costs associated with traditional cell counting methods in cleanroom environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Overcount.